ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV) - PubMed (original) (raw)
Guideline
doi: 10.1093/annonc/mdi805.
Affiliations
- PMID: 15888767
- DOI: 10.1093/annonc/mdi805
Free article
Guideline
ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
J Herrstedt et al. Ann Oncol. 2005.
Free article
No abstract available
Similar articles
- ESMO Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV).
ESMO.. ESMO.. Ann Oncol. 2001 Aug;12(8):1059-60. doi: 10.1023/a:1017413507554. Ann Oncol. 2001. PMID: 11583185 No abstract available. - Controlling chemotherapy-related nausea and vomiting.
Herrstedt J. Herrstedt J. Lancet Oncol. 2009 Jun;10(6):636. doi: 10.1016/S1470-2045(09)70091-9. Lancet Oncol. 2009. PMID: 19482253 No abstract available. - Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.
Herrstedt J, Roila F; ESMO Guidelines Working Group. Herrstedt J, et al. Ann Oncol. 2008 May;19 Suppl 2:ii110-2. doi: 10.1093/annonc/mdn105. Ann Oncol. 2008. PMID: 18456745 No abstract available. - Comparative activity of antiemetic drugs.
Jordan K, Schmoll HJ, Aapro MS. Jordan K, et al. Crit Rev Oncol Hematol. 2007 Feb;61(2):162-75. doi: 10.1016/j.critrevonc.2006.08.003. Crit Rev Oncol Hematol. 2007. PMID: 17208005 Review. - [Prophylaxis of chemotherapy-induced vomiting and nausea].
Tóth J, Szántó J. Tóth J, et al. Magy Onkol. 2008 Dec;52(4):391-4. doi: 10.1556/MOnkol.52.2008.4.9. Magy Onkol. 2008. PMID: 19068468 Review. Hungarian.
Cited by
- Analysis of Dietary Intake during Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas.
Hori Y, Sakamoto A, Goto T, Ando S, Yamashita M, Shimomura M, Uemura T. Hori Y, et al. Front Nutr. 2018 Jan 22;4:70. doi: 10.3389/fnut.2017.00070. eCollection 2017. Front Nutr. 2018. PMID: 29404330 Free PMC article. - Protein calorie malnutrition, nutritional intervention and personalized cancer care.
Gangadharan A, Choi SE, Hassan A, Ayoub NM, Durante G, Balwani S, Kim YH, Pecora A, Goy A, Suh KS. Gangadharan A, et al. Oncotarget. 2017 Apr 4;8(14):24009-24030. doi: 10.18632/oncotarget.15103. Oncotarget. 2017. PMID: 28177923 Free PMC article. Review. - Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population.
Tian W, Wang Z, Zhou J, Zhang S, Wang J, Chen Q, Huang C, Pan L, Zhang L, Huang J, Shen H, Lin T. Tian W, et al. Med Oncol. 2011 Mar;28(1):71-8. doi: 10.1007/s12032-009-9398-2. Epub 2010 Jan 5. Med Oncol. 2011. PMID: 20049561 Clinical Trial. - Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer.
Eberhardt WE, Mitchell P, Schiller JH, Brown MP, Thomas M, Mills G, Jehl V, Urva SR, De Leo JJ, Gogov S, Papadimitrakopoulou V. Eberhardt WE, et al. Invest New Drugs. 2014 Feb;32(1):123-34. doi: 10.1007/s10637-013-9958-3. Epub 2013 Apr 12. Invest New Drugs. 2014. PMID: 23579358
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical